Shelter Pharma
add_icon

Shelter Pharma

30.99
+0.88
(2.92%)
Market Cap
51.46 Cr
PE Ratio
6.91
Volume
9,000.00
Day High - Low
30.99 - 30.88
52W High-Low
50.00 - 26.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
51.46 Cr
EPS
6.26
PE Ratio
6.91
PB Ratio
0.84
Book Value
35.81
EBITDA
10.10
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
16.94
Debt to Equity
0.02
Forecast For
Actual

Company News

View All News
Caret
positive
Shelter Pharma Limited has started dispatching products including Allvitamin supplement to Sudan on April 15, 2026, as part of its regular export operations to African markets under SEBI Regulation 30.
positive
Shelter Pharma Limited announces strategic appointments including Zonal Sales Manager, Regional Sales Manager, Sales Officers, and Export Executive to strengthen sales organization and expand market presence.
neutral
Shelter Pharma Limited informs BSE that Annual Secretarial Compliance report under Regulation 24A is not applicable as it is listed on SME platform, exempting it from specific SEBI regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,620.40
#1 3,88,788.24
36.80
#1 54,729.00
9.71
#1 10,980
16.07
33.27
6,361.50
1,68,877.84
68.31
9,712.00
18.67
2,191
-1.02
63.24
4,117.20
1,39,344.76
61.76
11,539.40
6.99
1,911
26.24
45.65
1,317.10
1,09,930.83
20.15
33,741.20
16.73
5,725
-15.28
61.94
2,296.10
1,04,941.69
22.91
22,909.50
13.74
3,306
#1 37.44
47.90
1,295.00
1,04,607.60
23.27
28,409.50
7.12
5,291
-57.18
60.61
2,267.40
93,599.42
52.47
12,744.20
#1 20.90
2,007
7.65
67.86
927.40
93,318.14
#1 18.96
23,511.00
18.55
4,615
-0.32
55.15
1,413.80
82,113.73
23.93
32,345.60
9.43
3,484
7.59
66.95
2,299.50
64,892.08
61.93
13,435.50
6.18
1,047
15.86
63.32
Growth Rate
Revenue Growth
26.75 %
Net Income Growth
16.13 %
Cash Flow Change
379.59 %
ROE
-2.14 %
ROCE
-1.88 %
EBITDA Margin (Avg.)
-7.19 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
30
23
30
36
40
51
0
Expenses
30
22
27
28
32
41
0
EBITDA
0
0
3
8
9
10
0
Operating Profit %
1 %
1 %
10 %
22 %
21 %
20 %
0 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
3
7
8
10
0
Tax
0
0
1
2
2
2
0
Net Profit
0
0
2
5
6
7
0
EPS in ₹
1.77
0.88
42.54
6.72
5.36
6.26
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
11
10
13
21
38
48
Fixed Assets
2
2
2
2
4
6
Current Assets
8
8
10
19
30
33
Capital Work in Progress
0
0
1
0
0
0
Investments
0
0
0
0
0
0
Other Assets
9
9
11
20
34
42
Total Equity & Liabilities
11
10
13
21
38
48
Current Liabilities
4
3
4
6
2
5
Non Current Liabilities
0
0
0
1
1
1
Total Equity
7
7
9
15
36
43
Reserve & Surplus
7
7
8
7
24
31
Share Capital
1
1
1
8
12
12

Cash Flow

Cash Flow
2017
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
0
5
-2
Investing Activities
0
0
0
-1
0
-4
-7
Operating Activities
0
-0
-0
1
0
-2
6
Financing Activities
0
0
1
0
0
11
0

Share Holding

% Holding
Aug 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Aug 2025
Sept 2025
Oct 2025
Nov 2025
Mar 2026
Promoter
56.89 %
56.89 %
56.89 %
54.97 %
52.32 %
52.32 %
52.32 %
46.98 %
47.19 %
44.99 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.22 %
30.18 %
30.23 %
40.12 %
43.24 %
42.69 %
42.82 %
48.66 %
49.32 %
50.40 %
Others
13.89 %
12.93 %
12.88 %
4.91 %
4.44 %
4.99 %
4.86 %
4.36 %
3.49 %
4.61 %
No of Share Holders
1,165
836
868
1,119
1,153
1,109
1,094
1,094
1,093
1,071

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Sept 2024 DIVIDEND Dividend
₹ 0.33 /share
23 Sept 2024 46.97 48.21
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 46.97 47.50
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 46.88 47.15
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 38.00 39.50
23 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
23 Jul 2025 39.60 43.97
23 Sept 2025 DIVIDEND Dividend
₹ 0.35 /share
23 Sept 2025 45.00 43.27
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 45.00 44.00
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 41.50 41.86

Announcements

Intimation Under Regulation 30 Update On Export Operation9 days ago
Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion Plans10 days ago
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclousure Requirements ) Regulation 2015 For Hiring Of Senior Management Personnel In Line With Business Expansion PlansApr 07, 2026
Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements ) Regulation 2015 Reciept Of Negotiation Meeting Intimation From Verka Dairies ( Punjab State Co Operative Milk Producers Federation Limited )Apr 06, 2026
Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclousures Requirements) Regulations 2015 Positive Customer Feedback On Companies ProductsApr 02, 2026
Intimation Under Regulation 30 Of SEBI ( LODR ) New Product Now Available In The MarketApr 01, 2026
Closure of Trading WindowMar 26, 2026
Intimitation Under Regulation 30 Third Party Food Safety Audit Under FSSAI Regulatory FrameworkMar 18, 2026
Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements) Regulation 2015 - Appointment Of Investor Relation And Public Relation AuthorityMar 13, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 12, 2026
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMar 07, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday March 07 2026Mar 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 27, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 23, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 15, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 12, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesNov 17, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday November 17 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only) Nov 17, 2025
Announcement under Regulation 30 (LODR)-AllotmentNov 15, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 15 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only)Nov 15, 2025
Intimation With Regards To Shelter Pharma Received ISO 22000:2018 CertificationNov 11, 2025
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 10, 2025
Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025Nov 10, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025Nov 10, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 06, 2025
Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On 10Th November 2025Nov 05, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 03, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 16, 2025
Board Meeting Outcome for 861000 Equity Shares Allotted Pursuant To Conversion Of Warrants Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 03, 2025
Board Meeting Outcome for 1128000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.Oct 03, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 01, 2025
Board Meeting Outcome for Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.Oct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 29, 2025
Intimation Of Shelter PharmaS Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing RegulationsSep 23, 2025
Shelter Pharma Limited Embarks On Sustainability Journey With The Installation Of A 15 KW Solar Power Plant At Its Factory Situated At Shelter Nagar Nr. S. T. Bus Stand Himmatnagar Gujarat India 383001Sep 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Notice Of 18Th Annual General MeetingSep 06, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 02, 2025

Technical Indicators

RSI(14)
Neutral
47.30
ATR(14)
Less Volatile
1.59
STOCH(9,6)
Neutral
34.02
STOCH RSI(14)
Neutral
43.08
MACD(12,26)
Bullish
0.15
ADX(14)
Weak Trend
15.11
UO(9)
Bearish
43.08
ROC(12)
Uptrend And Accelerating
3.03
WillR(14)
Neutral
-54.68